Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $1.52B | $858.44M | $640.80M | $714.72M |
| Net Income | $602.75M | $268.63M | $210.26M | $247.76M |
| EPS Diluted | $2.29 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $1.03 |
| $0.81 |
| $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.